Next US FDA Generics Leader Must Have ‘Frank Conversations’ With Colleagues, Industry, Former OGD Director Says

 
• By Derrick Gingery
Leadership change
Rosencrance is a 30-year veteran of the FDA, including 24 years spent working in OGD. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics